Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

1.

Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.

Schlundt A, Günther S, Sticht J, Wieczorek M, Roske Y, Heinemann U, Freund C.

J Mol Biol. 2012 Oct 26;423(3):294-302. doi: 10.1016/j.jmb.2012.07.008. Epub 2012 Jul 20.

PMID:
22820093
[PubMed - indexed for MEDLINE]
2.

Bidirectional binding of invariant chain peptides to an MHC class II molecule.

Günther S, Schlundt A, Sticht J, Roske Y, Heinemann U, Wiesmüller KH, Jung G, Falk K, Rötzschke O, Freund C.

Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22219-24. doi: 10.1073/pnas.1014708107. Epub 2010 Nov 29.

PMID:
21115828
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.

Ghosh P, Amaya M, Mellins E, Wiley DC.

Nature. 1995 Nov 30;378(6556):457-62.

PMID:
7477400
[PubMed - indexed for MEDLINE]
4.

T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.

Morkowski S, Goldrath AW, Eastman S, Ramachandra L, Freed DC, Whiteley P, Rudensky AYu.

J Exp Med. 1995 Nov 1;182(5):1403-13.

PMID:
7595211
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.

Fujii S, Senju S, Chen YZ, Ando M, Matsushita S, Nishimura Y.

Hum Immunol. 1998 Oct;59(10):607-14.

PMID:
9757942
[PubMed - indexed for MEDLINE]
6.
7.
8.

The MHC class II-associated invariant chain-derived peptide clip binds to the peptide-binding groove of class II molecules.

Wu S, Gorski J.

Mol Immunol. 1996 Mar-Apr;33(4-5):371-7.

PMID:
8676888
[PubMed - indexed for MEDLINE]
9.

Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.

Carstens C, Newman DK, Bohlen H, König A, Koch N.

Int Immunol. 2000 Nov;12(11):1561-8.

PMID:
11058576
[PubMed - indexed for MEDLINE]
Free Article
10.

Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules.

Bangia N, Watts TH.

Int Immunol. 1995 Oct;7(10):1585-91.

PMID:
8562503
[PubMed - indexed for MEDLINE]
11.

MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.

Malcherek G, Wirblich C, Willcox N, Rammensee HG, Trowsdale J, Melms A.

Eur J Immunol. 1998 May;28(5):1524-33.

PMID:
9603457
[PubMed - indexed for MEDLINE]
12.

Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.

Xu M, Jackson R, Adams S, Humphreys RE.

Arzneimittelforschung. 1999 Sep;49(9):791-9.

PMID:
10514908
[PubMed - indexed for MEDLINE]
13.

Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.

Thayer WP, Ignatowicz L, Weber DA, Jensen PE.

J Immunol. 1999 Feb 1;162(3):1502-9.

PMID:
9973407
[PubMed - indexed for MEDLINE]
Free Article
14.

Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

Stumptner P, Benaroch P.

EMBO J. 1997 Oct 1;16(19):5807-18.

PMID:
9312039
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM.

Verreck FA, Fargeas CA, Hämmerling GJ.

Eur J Immunol. 2001 Apr;31(4):1029-36.

PMID:
11298327
[PubMed - indexed for MEDLINE]
16.

Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif.

Zhu Y, Rudensky AY, Corper AL, Teyton L, Wilson IA.

J Mol Biol. 2003 Feb 28;326(4):1157-74.

PMID:
12589760
[PubMed - indexed for MEDLINE]
17.

Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.

Wälchli S, Kumari S, Fallang LE, Sand KM, Yang W, Landsverk OJ, Bakke O, Olweus J, Gregers TF.

Eur J Immunol. 2014 Mar;44(3):774-84. doi: 10.1002/eji.201343671. Epub 2013 Dec 27.

PMID:
24293164
[PubMed - indexed for MEDLINE]
18.

Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions.

Murray JS, Fois SD, Schountz T, Ford SR, Tawde MD, Brown JC, Siahaan TJ.

J Pept Res. 2002 Mar;59(3):115-22.

PMID:
11985705
[PubMed - indexed for MEDLINE]
19.

Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cells.

van Luijn MM, van de Loosdrecht AA, Lampen MH, van Veelen PA, Zevenbergen A, Kester MG, de Ru AH, Ossenkoppele GJ, van Hall T, van Ham SM.

PLoS One. 2012;7(4):e34649. doi: 10.1371/journal.pone.0034649. Epub 2012 Apr 26.

PMID:
22563374
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.

Malcherek G, Gnau V, Jung G, Rammensee HG, Melms A.

J Exp Med. 1995 Feb 1;181(2):527-36.

PMID:
7836909
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk